Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*

por Borissov, Borislav, Urbich, Michael, Georgieva, Boryana, Tsenov, Svetoslav, Villa, Guillermo
Publicado 2017